Anavex Life Sciences Corp. Company Profile (NASDAQ:AVXL)

Analyst Ratings

Consensus Ratings for Anavex Life Sciences Corp. (NASDAQ:AVXL) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.50 (225.52% upside)

Analysts' Ratings History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Show:
DateFirmActionRatingPrice TargetActions
7/27/2016Maxim GroupSet Price TargetBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/26/2016FBR & CoReiterated RatingOutperform$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/15/2016        
5/11/2016Q2($0.16)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/8/2016Q116($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/29/2015Q4($0.06)($0.65)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Anavex Life Sciences Corp. (NASDAQ:AVXL)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.14)($0.14)($0.14)
Q2 20161($0.14)($0.14)($0.14)
Q3 20161($0.09)($0.09)($0.09)
Q4 20161($0.08)($0.08)($0.08)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/14/2015Christopher U MisslingCEOBuy1,000$0.52$520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/13/2015Christopher U MisslingCEOBuy1,000$0.53$530.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2015Christopher U MisslingCEOBuy2,000$0.49$980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Christopher U MisslingCEOBuy2,000$0.45$900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2015Christopher U MisslingCEOBuy1,000$0.47$470.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/22/2015Christopher U MisslingCEOBuy1,000$0.42$420.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2015Christopher U MisslingCEOBuy1,000$0.44$440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Christopher U MisslingCEOBuy1,000$0.43$430.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Christopher U MisslingCEOBuy1,000$0.36$360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2015Christopher U MisslingCEOBuy1,000$0.35$350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Christopher U MisslingCEOBuy1,000$0.37$370.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Anavex Life Sciences Corp. (NASDAQ:AVXL)
DateHeadline
07/29/16 02:42 PMStocks to Seek Now: Anavex Life Sciences Corp. (NASDAQ:AVXL), EPIRUS Biopharmaceuticals (NASDAQ:EPRS) - News Oracle
07/28/16 03:45 PMAnavex Will Head Much, Much Lower - Seeking Alpha
07/28/16 03:45 PMOptions Hot as Anavex Life Sciences Corp. (AVXL) Gaps Lower - Schaeffers Research (blog)
07/28/16 03:45 PMAnavex Life Sciences Corp (NASDAQ:AVXL) Correction Presents Opportunity - Insider Financial
07/28/16 12:11 PMHere Is Why These Five Stocks Are Among Today’s Biggest Losers -
07/27/16 08:27 PMAnavex Presents 31-Week Efficacy Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer’s Patients at AAIC 2016
07/27/16 08:27 PMAnavex Life Sciences (AVXL) Presents Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer's Patients at AAIC
07/27/16 08:27 PMCapitalizing On The Anavex Life Sciences Corp (NASDAQ:AVXL) Catalysts
07/27/16 08:27 PMOptions Hot as Anavex Life Sciences Corp. (AVXL) Gaps Lower
07/27/16 03:51 PMWhy Anavex Life Sciences Corp. Just Imploded - Disappointing Phase 2a study results from Anavex's lead compound sends its shares reeling.
07/27/16 02:42 PMAnavex Life Sciences (AVXL) Presents Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer's Patients at AAIC - StreetInsider.com
07/27/16 01:38 PMAnavex Alzheimer's Drug Plays Losing Game Against Placebo Effect -
07/27/16 11:09 AMAnalyst's Valuable Buzzers: Cardiome Pharma Corporation (NASDAQ:CRME) , Anavex Life Sciences Corp (NASDAQ ... - Street Updates
07/27/16 11:09 AMFBR Weighs In on Anavex Life Sciences Corp. (AVXL) Following ... - Smarter Analyst
07/26/16 02:31 PMNews review of 2 biotech stocks: Anavex Life Sciences Corp. (NASDAQ:AVXL), ImmunoGen, Inc. (NASDAQ:IMGN) - The Voice Registrar
07/26/16 02:31 PMAnalyst Consideration on this Stock: Anavex Life Sciences Corp. (NASDAQ:AVXL) - News Oracle
07/25/16 03:12 PMHeat Biologics Inc (NASDAQ:HTBX) & Anavex Life Sciences Corp (OTCMKTS:AVXL) Stocks to Watch - Wall Street 24
07/25/16 01:37 AM2:37 am Anavex presents 31-week safety data from Phase 2a Study of ANAVEX 2-73; results feature favorable safety, positive dose response as well as positive unexpected therapeutic response events -
07/24/16 08:30 AMAnavex Presents 31-Week Safety Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer’s Patients at AAIC 2016 - [GlobeNewswire] - Results Feature Favorable Safety, Maximum Tolerated Dose, Positive Dose Response as well as Positive Unexpected Therapeutic Response Events. NEW YORK, July 24, 2016-- Anavex Life Sciences Corp., a clinical-stage ...
07/23/16 02:41 PMAnavex Life Sciences Corp. (NASDAQ:AVXL) Insider Activities Are in the Air - Review Fortune
07/22/16 02:39 PMThe Exciting Story of Anavex Life Sciences Corp.(NASDAQ:AVXL) - MicroCap Daily
07/21/16 02:41 PMMylan N.V. (NASDAQ:MYL) Increased 5.05%: Anavex Life Sciences Corp. (NASDAQ:AVXL), Yingli Green Energy ... - KC Register
07/20/16 10:45 AMHeightened Volatility Spotted on Shares of: Anavex Life Sciences Corp. (:AVXL) - Engelwood Daily
07/18/16 02:44 PMInvestor Watch: Volatility Recap on Shares of: Anavex Life Sciences Corp. (:AVXL) - Engelwood Daily
07/18/16 02:44 PMAnavex Life Sciences Corp (OTCMKTS:AVXL)'s Company Shares Increased 64.57% After Low Volatility - Press Telegraph
07/17/16 07:24 AMShares Moving Down on the Week: Anavex Life Sciences Corp. (:AVXL) - Engelwood Daily
07/16/16 09:34 AMIncreased Volatility Noted on Shares of: Anavex Life Sciences Corp. (:AVXL) - Engelwood Daily
07/14/16 11:33 AMAnavex Life Sciences Corp. Shot 38% Higher in June -- Here's Why - Madison.com
07/14/16 11:33 AMTraders Actions to Focus: Biogen Inc. (NASDAQ:BIIB) , Anavex Life Sciences Corp. (NASDAQ:AVXL) - Street Updates
07/13/16 07:04 PMAnavex Life Sciences Corp. Shot 38% Higher in June -- Here's Why - Preclinical data powers Anavex in June, but plenty of risks remain.
07/12/16 02:44 PMAnalysts Watching Stocks Update: Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) , Anavex Life Sciences Corp ... - Street Updates
07/12/16 02:44 PMBiotech news that matter for investors: Anavex Life Sciences (AVXL), CTI BioPharma (NASDAQ:CTIC) - The Voice Registrar
07/12/16 02:44 PMSession Volatility Review for: Anavex Life Sciences Corp. (:AVXL) - Engelwood Daily
07/12/16 06:00 AMAnavex to Present at the Alzheimer’s Association International Conference (AAIC) 2016 - [GlobeNewswire] - NEW YORK, July 12, 2016-- Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases ...
07/11/16 07:42 PMStock Volatility Focus for: Anavex Life Sciences Corp. (:AVXL) - Engelwood Daily
07/11/16 02:39 PMStock Pushing HIgher in Session: Anavex Life Sciences Corp. (:AVXL) - Telanagana Press
07/11/16 07:29 AMStock on the Rise for the Quarter: Anavex Life Sciences Corp. (:AVXL) - Engelwood Daily
07/09/16 10:33 AMAnavex Life Sciences Corp. (NASDAQ:AVXL): We Bought The Stock At $6.25 And Made massive 25% - Market News Call
07/08/16 02:40 PMAnavex Life Sciences Corp. (NASDAQ:AVXL): Updated Analyst Ratings - Review Fortune
07/08/16 02:40 PMAnavex Life Sciences Corp. Stock Momentum Hits Strength - CML News
07/08/16 10:42 AMBioMarin Pharmaceutical (BMRN) Jumps: Stock Rises 9.1%
07/08/16 10:42 AMAnavex Life Sciences Corp. (NASDAQ:AVXL): Our Subscribers Are Already Up 19% In 2 Sessions
07/08/16 08:03 AMKite (KITE) Enrolls ZUMA-1 Study, Interim Data, Filing in 2016 -
07/07/16 07:54 PMJobs Growth Spurs Boon to Stocks on Thursday
07/07/16 04:19 PMANAVEX LIFE SCIENCES CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex -
07/07/16 02:40 PMStock Moving Up in Trading: Anavex Life Sciences Corp. (:AVXL) - Telanagana Press
07/07/16 02:40 PMPerformance report of the company: Anavex Life Sciences Corp. (NASDAQ:AVXL) - News Oracle
07/01/16 02:44 PMA Major Breakout On Anavex Life Sciences Corp (NASDAQ:AVXL) - Insider Financial
07/01/16 07:25 AMAnavex Life Sciences (AVXL) in Focus: Stock Rises 16.4% -
06/30/16 02:51 PMUpdate on Stock Volatility for: Anavex Life Sciences Corp. (:AVXL) - Engelwood Daily

Social

About Anavex Life Sciences Corp.

Anavex Life Sciences Corp. logoAnavex Life Sciences Corp., is a clinical-stage biopharmaceutical company engaged in the development of drug candidates. The Company's lead compounds include ANAVEX 2-73, ANAVEX PLUS, a combination of ANAVEX 2-73 with donepezil (Aricept), ANAVEX 19-144, ANAVEX 1-41, ANAVEX 7-1037, ANAVEX 3-71, ANAVEX 1079, ANAVEX 1519 and ANAVEX 1066 being developed to treat Alzheimer's disease and other central nervous system (CNS) diseases. The Company's SIGMACEPTOR Discovery Platform produced small molecule drug candidates with unique modes of action. Sigma receptors may be targets for therapeutics to combat many human diseases, including Alzheimer's disease. When bound by the appropriate ligands, sigma receptors influence the functioning of multiple biochemical signals that are involved in the pathogenesis (origin or development) of disease.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AVXL
  • CUSIP:
Key Metrics:
  • Previous Close: $3.51
  • 50 Day Moving Average: $5.68
  • 200 Day Moving Average: $4.88
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $136.06M
  • Beta: 0.05
  • Current Year EPS Consensus Estimate: $-0.34 EPS
  • Next Year EPS Consensus Estimate: $-0.62 EPS
Additional Links:
Anavex Life Sciences Corp. (NASDAQ:AVXL) Chart for Friday, July, 29, 2016